The wound healing process is recognized to be a
dynamic balance between growth factors, or the
synthetic aspects, and proteases, which
produce tissue breakdown and remodeling.
These proteases therefore break down the
elements of a wound namely collagen, elastin,
and matrix. In addition, these proteases will
inactivate growth factors if present in excess
as in a chronic wound or an acute burn wound.
There is present a counteraction system to
maintain optimum balance in the wound called
endogenous tissue inhibitors of MMP’s or TIMP’s.
There are a number of TIMP’s, released by
macrophages and fibroblasts, in response to MMP
production which protect tissue from protease
breakdown by a competitive binding to tissue
protease sites.
This system is limited to a finite production,
which can be overwhelmed by the greater
potential for protease production with
inflammation. At present, considerable research
is underway to increase TIMP’s activity.
Presently, there are no clinically available
protease inhibitors.